Palantir a high-risk investment with ’a one-of-a-kind growth and margin model’
In a recent transaction, Sujoda Management, LLC acquired a significant number of shares in Amkor Technology , Inc. (NASDAQ:AMKR), a prominent player in the Semiconductors & Semiconductor Equipment industry with a market capitalization of $5.4 billion. The transaction, which took place on February 24, 2025, involved the purchase of 869,565 shares of Amkor’s common stock at a price of $21.85 per share. This acquisition amounts to a total value of approximately $18.9 million. According to InvestingPro analysis, the stock is currently trading near its 52-week low of $21.46.
The shares were acquired through Sujoda Investments, LP, with Sujoda Management acting as the sole general partner. This purchase increases Sujoda Investments’ total holdings to 3,347,890 shares. The acquisition was part of a transaction between members of the Kim family group, as noted in the filing. The timing is notable as Amkor’s stock has experienced a significant decline, down 33% over the past six months. InvestingPro analysis indicates the stock is currently undervalued, with 12+ additional exclusive insights available to subscribers.
It’s important to note that Sujoda Management has stated that it disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest. This disclaimer is made under the guidelines of Section 16 of the Securities Exchange Act of 1934. The company maintains strong fundamentals with a current ratio of 2.11, indicating healthy liquidity, and analysts have set price targets ranging from $24 to $36 per share.
In other recent news, Amkor Technology reported fourth-quarter earnings that exceeded analyst expectations, with adjusted earnings per share of $0.43, surpassing the estimated $0.38. However, revenue for the quarter was $1.63 billion, slightly below the consensus estimate of $1.66 billion and down 7% year-over-year. The company’s guidance for the first quarter of 2025 fell short, projecting earnings per share between $0.01 and $0.17, significantly below the consensus of $0.31. Revenue is also expected to be lower, between $1.225 billion and $1.325 billion, compared to the anticipated $1.464 billion.
Analysts have responded with mixed assessments. KeyBanc Capital Markets reduced its price target for Amkor to $27.00 from $34.00 while maintaining an Overweight rating, citing a cautious outlook for 2025. DA Davidson, on the other hand, maintained a Buy rating with a price target of $36.00, expressing optimism about Amkor’s potential recovery. UBS adjusted its price target to $27.65 from $32.50, keeping a Neutral rating due to concerns about sales guidance and capital expenditure growth.
Amkor’s full-year 2024 net sales were $6.32 billion, down from $6.50 billion in 2023, with net income slightly decreasing. Despite challenges, the company noted positive developments such as the ramp-up of its Vietnam facility and securing CHIPS funding. The board approved a 5% increase in the quarterly cash dividend and a special cash dividend, emphasizing a focus on shareholder returns.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.